Bradford, D. W., Shampine, L. J., Harris, V. P., Naylor, J. C., Massing, M. W., Lieberman, J. A., … Marx, C. E. (2006). Pregnenolone alterations in parietat cortex are associated with death by suicide in patients with schizophrenia. In Neuropsychopharmacology (Vol. 31, pp. S118–S119). Hollywood, FL: NATURE PUBLISHING GROUP.

Bradford, Daniel W., Lawrence J. Shampine, Victoria P. Harris, Jennifer C. Naylor, Mark W. Massing, Jeffrey A. Lieberman, A. L. Morrow, and Christine E. Marx. “Pregnenolone alterations in parietat cortex are associated with death by suicide in patients with schizophrenia.” In Neuropsychopharmacology, 31:S118–19. NATURE PUBLISHING GROUP, 2006.

Bradford DW, Shampine LJ, Harris VP, Naylor JC, Massing MW, Lieberman JA, et al. Pregnenolone alterations in parietat cortex are associated with death by suicide in patients with schizophrenia. In: Neuropsychopharmacology. NATURE PUBLISHING GROUP; 2006. p. S118–9.

Bradford, Daniel W., et al. “Pregnenolone alterations in parietat cortex are associated with death by suicide in patients with schizophrenia.” Neuropsychopharmacology, vol. 31, NATURE PUBLISHING GROUP, 2006, pp. S118–19.

Bradford DW, Shampine LJ, Harris VP, Naylor JC, Massing MW, Lieberman JA, Morrow AL, Marx CE. Pregnenolone alterations in parietat cortex are associated with death by suicide in patients with schizophrenia. Neuropsychopharmacology. NATURE PUBLISHING GROUP; 2006. p. S118–S119.